|
1
|
Sitarz R, Skierucha M, Mielko J, Offerhaus
GJA, Maciejewski R and Polkowski WP: Gastric cancer: Epidemiology,
prevention, classification, and treatment. Cancer Manag Res.
10:239–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen L, Li J, Xu J, Pan H, Dai G, Qin S,
Wang L, Wang J, Yang Z, Shu Y, et al: Bevacizumab plus capecitabine
and cisplatin in Chinese patients with inoperable locally advanced
or metastatic gastric or gastroesophageal junction cancer:
Randomized, double-blind, phase III study (AVATAR study). Gastric
Cancer. 18:168–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeng H, Zheng R, Guo Y, Zhang S, Zou X,
Wang N, Zhang L, Tang J, Chen J, Wei K, et al: Cancer survival in
China, 2003–2005: A population-based study. Int J Cancer.
136:1921–1930. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Buckland G, Travier N, Huerta JM,
Bueno-de-Mesquita HB, Siersema PD, Skeie G, Weiderpass E, Engeset
D, Ericson U, Ohlsson B, et al: Healthy lifestyle index and risk of
gastric adenocarcinoma in the EPIC cohort study. Int J Cancer.
137:598–606. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Massarrat S and Stolte M: Development of
gastric cancer and its prevention. Arch Iran Med. 17:514–520.
2014.PubMed/NCBI
|
|
7
|
Rao SA, Santosh V and Somasundaram K:
Genome-wide expression profiling identifies deregulated miRNAs in
malignant astrocytoma. Mod Pathol. 23:1404–1417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L,
Meng WB, Zhu KX, Ding FH, Miao L, Yan J, et al: Plasma microRNAs as
potential new biomarkers for early detection of early gastric
cancer. World J Gastroenterol. 25:1580–1591. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Zhu X, Shou T, Yang L, Cheng X, Wang
J, Deng L and Zheng Y: MicroRNA-28 promotes cell proliferation and
invasion in gastric cancer via the PTEN/PI3K/AKT signalling
pathway. Mol Med Rep. 17:4003–4010. 2018.PubMed/NCBI
|
|
10
|
Peng QP, Du DB, Ming Q, Hu F, Wu ZB and
Qiu S: MicroRNA 494 increases chemosensitivity to doxorubicin in
gastric cancer cells by targeting phosphodiesterases 4D. Cell Mol
Biol. 64:62–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu WQ, Liu L and Yu Z: Clinical value of
microRNA-23a upregulation in non-small cell lung cancer. Int J Clin
Exp Med. 8:13598–13603. 2015.PubMed/NCBI
|
|
12
|
Zhang XW, Liu N, Chen S, Wang Y, Zhang ZX,
Sun YY, Qiu GB and Fu WN: High microRNA-23a expression in laryngeal
squamous cell carcinoma is associated with poor patient prognosis.
Diagn Pathol. 10:222015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang N and Zhang T: Downregulation of
MicroRNA-135 promotes sensitivity of non-small cell lung cancer to
Gefitinib by targeting TRIM16. Oncol Res. 26:1005–1014. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Virgilio E, Proietti A, D'Urso R, Cardelli
P, Giarnieri E, Montagnini M, Giovagnoli MR, Mercantini P, Balducci
G and Cavallini M: Measuring intragastric tumor markers in gastric
cancer patients: A systematic literature review on significance and
reliability. Anticancer Res. 37:2817–2821. 2017.PubMed/NCBI
|
|
15
|
Xiao S, Feng F, Sun L, Cai L, Liu Z, Liu
S, Fan D and Zhang H: Blood type AB predicts promising prognosis in
gastric cancer patients with positive preoperative serum CEA.
Medicine (Baltimore). 96:e84962017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J,
Bostick RM, Wu X and Yuan Y: A serological biopsy using five
stomach-specific circulating biomarkers for gastric cancer risk
assessment: A multi-phase study. Am J Gastroenterol. 112:704–715.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Wang X H, Kou H J, et al:
Comparing single oral contrast-enhanced ultrasonography and double
contrast-enhanced ultrasonography in the preoperative Borrmann
classification of advanced gastric cancer. Oncotarget.
9:87162018.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okines A, Verheij M, Allum W, Cunningham D
and Cervantes A; ESMO Guidelines Working Group, : Gastric cancer:
ESMO Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 21 (Suppl 5):v50–v54. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng G, Qu J, Zhai S, Shi Y and Wang X:
Effect of neoadjuvant chemotherapy on nutritional status of locally
advanced gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi.
21:331–335. 2018.(In Chinese). PubMed/NCBI
|
|
21
|
Shen L, Shan YS, Hu HM, Price TJ, Sirohi
B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of
gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Harada K, Mizrak Kaya D, Shimodaira Y,
Song S, Baba H and Ajani JA: Proteomics approach to identify
biomarkers for upper gastrointestinal cancer. Expert Rev
Proteomics. 13:1041–1053. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qian B, Katsaros D, Lu L, Preti M, Durando
A, Arisio R, Mu L and Yu H: High miR-21 expression in breast cancer
associated with poor disease-free survival in early stage disease
and high TGF-beta1. Breast Cancer Res Treat. 117:131–140. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou J, Tian Y, Li J, Lu B, Sun M, Zou Y,
Kong R, Luo Y, Shi Y, Wang K, et al: miR-206 is down-regulated in
breast cancer and inhibits cell proliferation through the
up-regulation of cyclinD2. Biochem Biophys Res Commun. 433:207–212.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baranwal S and Alahari SK: miRNA control
of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290.
2010.PubMed/NCBI
|
|
26
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu LH, Liu T, Tang H, Tian RQ, Su C, Liu
M and Li X: MicroRNA-23a promotes the growth of gastric
adenocarcinoma cell line MGC803 and downregulates interleukin-6
receptor. FEBS J. 277:3726–3734. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou W, Li X, Liu F, Xiao Z, He M, Shen S
and Liu S: MiR-135a promotes growth and invasion of colorectal
cancer via metastasis suppressor 1 in vitro. Acta Biochim Biophys
Sin (Shanghai). 44:838–846. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Golubovskaya VM, Sumbler B, Ho B, Yemma M
and Cance WG: MiR-138 and MiR-135 directly target focal adhesion
kinase, inhibit cell invasion, and increase sensitivity to
chemotherapy in cancer cells. Anticancer Agents Med Chem. 14:18–28.
2014. View Article : Google Scholar : PubMed/NCBI
|
